Hangzhou Tigermed Consulting Co (HKSE:03347) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03347 Hangzhou Tigermed Consulting Co Ltd HKSE:03347
95 GF Score
Price HK$37.20
GF Value HK$49.30
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Hangzhou Tigermed Consulting Co FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:03347
95GF Score
Hangzhou Tigermed Consulting Co Ltd HKSE:03347
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hangzhou Tigermed Consulting Co (HKSE:03347) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued. The current stock price of HK$37.20 is trading 24.5% below its estimated GF Value™ of HK$49.30. GuruFocus considers Hangzhou Tigermed Consulting Co to be Modestly Undervalued.

Key valuation signals for HKSE:03347:

  • FFO:
  • GF Value™: HK$49.30 vs. price of HK$37.20 (24.5% below fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the HKSE:03347 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hangzhou Tigermed Consulting Co Business Description

Other Exchanges 5HZ1:Germany300347:China
Address No. 508 Lujiatan Street, Room 601-610, 6th Floor, Puyan Sub-District, Binjiang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
95GF Score

Get the complete analysis for HKSE:03347

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$37.20
Price
HK$49.30
GF Value